Saturday, December 21, 2024
Home Tags Miti

Tag: miti

Biotech Stock Review
All News

Biotech Stock Review Adds One Medical (ONEM) $28.50 to Watchlist.

Editor / Curator -
Mitesco Inc,. Biotech Stock Review
All News

Biotech Stock Review: Mitesco (MITI) $0.03, Report Update

Editor / Curator -
Biotech News

Update: Biotech 5 Pack. 5 Biotech Stocks, we Expected to Double...

Editor / Curator -
Telehealth

True Nature | Mitesco (MITI) Raising $15 Million.

Editor / Curator -
Biotech News

Our Favorite Incubator, Incubates! Telehealth in its Future?

Editor / Curator -
Superbug News - CoronaVirus Watch List

CoronaVirus Watch List Stocks in the News (Bloomberg, Benzinga).

Editor / Curator -
Mitesco, Biotech Stock Review
Incubator

Medtech Incubator True Nature | Mitesco (TNTY) Adds Another Heavy Hitter...

Editor / Curator -
All News

Citius Pharma (CTXR), Fortress Biotech (FBIO) and True Nature (TNTY) Significantly...

Editor / Curator -
Julie R Smith, True Nature, Mitesco
Interview

True Nature|Mitesco President & COO, Julie Smith Interview.

Editor / Curator -
Biotech News

True Nature|Mitesco (TNTY). Coverage Report Issued.

Editor / Curator -
1234Page 2 of 4

Latest article

Adding Quantum Pharmaceutical (QNTM) $4.10 to Reverse Split Stock Watch List.

All News Editor / Curator -
119% Gain Post Split

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.